Nektar Therapeutics (NKTR) Revenue Growth (3y) (2013 - 2026)
Nektar Therapeutics (NKTR) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 54.05% |
| 10 | Nektar Therapeutics | 1.75 Bn | 1.18 Bn | 3.16 Mn | -20.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.47% |
| Dec 31, 2025 | -0.33% |
| Sep 30, 2025 | -20.68% |
| Jun 30, 2025 | -19.70% |
| Mar 31, 2025 | -25.03% |
| Dec 31, 2024 | 5.27% |
| Sep 30, 2024 | -1.08% |
| Jun 30, 2024 | -6.06% |
| Mar 31, 2024 | -2.91% |
| Dec 31, 2023 | 0.60% |
| Sep 30, 2023 | -7.02% |
| Jun 30, 2023 | -25.13% |
| Mar 31, 2023 | -24.70% |
| Dec 31, 2022 | -13.36% |
| Sep 30, 2022 | -6.84% |
| Jun 30, 2022 | -2.54% |
| Mar 31, 2022 | -4.19% |
| Dec 31, 2021 | -14.37% |
| Sep 30, 2021 | -3.53% |
| Jun 30, 2021 | -70.36% |